Goat anti-TNF-R-II / TNFR2 (mouse) Antibody

Goat anti-TNF-R-II / TNFR2 (mouse) Antibody
Principle Name: TNF-R-II / TNFR2 (mouse)
Official Symbol: Tnfrsf1b
All Name and Symbols: Tnfrsf1b; tumor necrosis factor receptor superfamily, member 1B; CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR; TNF-R2; TNF-RII; TNFR-II; p75 TNF receptor; p80 TNF-alpha receptor; soluble TNFR1B variant 1; tumor necrosis fac
Accession Number(s): NP_035740.2
Peptide Sequence: KHFCNKTSDTVCAD, is from internal region
Non-Human GeneID(s): 21938 (mouse); 156767 (rat);
Important Comments: The immunizing peptide represents part of a potential extracellular domain.
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied As: lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20C. Minimize freezing and thawing.
Applications: Pep ELISA, WBPeptide ELISA: antibody detection limit dilution 1 to 8000.
Western Blot: Approx 55kDa band observed in Mouse and Rat Spinal Cord lysates (calculated MW of 50.3kDa according to Mouse NP_035740.2). Recommended concentration: 0.2-0.6ug/ml.
Reference(s): Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2010 Jul 20; 29:100.PMID: 20646319